Biomedical Engineering Reference
In-Depth Information
31. Schneider, O. D.; Loher, S.; Brunner, T. J.; Schmidlin, P.; Stark, W. J. Flexible, Lilver Con-
taining Nanocomposites for the Repair of Bone Defects: Antimicrobial Effect Against
E. coli
Infection and Comparison to Tetracycline Containing Scaffolds.
J. Mater. Chem.
2008,
18,
2679-2684.
32. Portilla-Arias, J. P.; Garcia-Alvarez, M.; Galbis, J. A.; Munoz-Guerra, S. Biodegradable
Nanoparticles of Partially Methylated Fungal Poly(beta-l-malic acid) as a Novel Protein
Delivery Carrier.
Macromol. Biosci.
2008,
8,
551-559.
33. Lacerda, L.; Soundararajan, A.; Singh, R.; Pastorin, G.; Al-Jamal, K. T.; Turton, J., et al.
Dynamic Imaging of Functionalized Multi-walled Carbon Nanotube Systemic Circulation
and Urinary Excretion.
Adv. Mater.
2008,
20,
225-230.
34. Klippstein, R.; Pozo, D. Nanotechnology-based Manipulation of Dendritic Cells for Enhanced
Immunotherapy Strategies.
Nanomed. Nanotechnol. Biol. Med.
2010,
6,
523-529.
35. de Jong, S.; Chikh, G.; Sekirov, L.; Raney, S.; Semple, S.; Klimuk, S., et al. Encapsulation in
Liposomal Nanoparticles Enhances the Immunostimulatory, Adjuvant and Anti-tumor Activ-
ity of Subcutaneously Administered CpG ODN.
Cancer Immunol. Immunother.
2007,
56,
1251-1264.
36. Goyal, A. K.; Khatri, K.; Mishra, N.; Mehta, A.; Vaidya, B.; Tiwari, S., et al. Aquasomes-a Nanopar-
ticulate Approach for the delivery of Antigen.
Drug Dev. Ind. Pharm.
2008,
34,
1297-1305.
37. Kortylewski, M.; Swiderski, P.; Herrmann, A.; Wang, L.; Kowolik, C.; Kujawski, M., et al.
In vivo Delivery of siRNA to Immune Cells by Conjugation to a TLR9 Agonist Enhances
Antitumor Immune Responses.
Nat. Biotechnol.
2009,
27,
925-932.
38. O'Hagan, D. T.; Singh, M. Microparticles as Vaccine Adjuvants and Delivery Systems.
Expert
Rev. Vaccines
2003,
2,
269-283.
39. Van Der Lubben, I. M.; Konings, F. A.; Borchard, G.; Verhoef, J. C.; Junginger-He, C. In vivo
Uptake of Chitosan Microparticles by Murine Peyer's Patches: Visualization Studies Using Con-
focal Laser Scanning Microscopy and Immunohistochemistry.
J. Drug Target.
2001,
9,
39-47.
40. Kreuter, J.; Ramge, P.; Petrov, V.; Hamm, S.; Gelperina, S. E.; Engelhardt, B.;
Alyautdin, R.; von Briesen, H.; Begley, D. J. Direct Evidence that Polysorbate-80-coated
Poly(butylcyanoacrylate) Nanoparticles Deliver Drugs to the CNS via Specific Mechanisms
Requiring Prior Binding of Drug to the Nanoparticles.
Pharm. Res.
2003,
20
.
41. Hoet, P. H.; Bruske-Hohfeld, I.; Salata, O. V. Nanoparticles -Known and Unknown Health
Risks.
J. Nanobiotechnol.
2004,
2,
12.
42. Nel, A.; Xia, T.; Madler, L.; Li, N. Tox Potential of Materials at the Nanolevel.
Science
2006,
311,
622-627.
43. Colvin, V. L. The Potential Environmental Impact of Engineered Nanomaterials.
Nat. Biotech-
nol.
2003,
21,
1166-1170.
44. Lovric, J.; Bazzi, H. S.; Cuie, Y.; Fortin, G. R.; Winnik, F. M.; Maysinger, D. Differences in
Subcellular Distribution and Toxicity of Green and Red Emitting CdTe Quantum Dots.
J. Mol.
Med.
2005,
83,
377-385.
45. Hardman, R. A Toxicologic Review of Quantum Dots: Toxicity Depends on Physicochemical
and Environmental Factors.
Environ. Health Perspect.
2006,
114,
165-172.
46. Borm, P. J.; Kreyling, W. Toxicological Hazards of Inhaled Nanoparticles-potential Implica-
tions for Drug Delivery.
J. Nanosci. Nanotech.
2004,
4,
521-531.
47. Portney, N. G.; Ozkan, M. Nano-oncology: Drug Delivery, Imaging, and Sensing.
Anal.
Bioanal. Chem.
2006,
384,
620-630.
48. Eun, H. C.; Chung, J. H.; Jung, S. Y.; Cho, K. H.; Kim, K. H. A Comparative Study of the
Cytotoxicity of Skin Irritants on Cultured Human Oral and Skin Keratinocytes.
Br. J. Dermatol.
1994,
130,
24-28.
